Follow
Lieuwe D. Bos
Lieuwe D. Bos
Amsterdam UMC
Verified email at amsterdamumc.nl - Homepage
Title
Cited by
Cited by
Year
Autoantibodies against type I IFNs in patients with life-threatening COVID-19
P Bastard, LB Rosen, Q Zhang, E Michailidis, HH Hoffmann, Y Zhang, ...
Science 370 (6515), eabd4585, 2020
25112020
Inborn errors of type I IFN immunity in patients with life-threatening COVID-19
Q Zhang, P Bastard, Z Liu, J Le Pen, M Moncada-Velez, J Chen, M Ogishi, ...
Science 370 (6515), eabd4570, 2020
21662020
Mapping the human genetic architecture of COVID-19
Writing group Writing group leaders Pathak Gita A. 6 Andrews Shea J. 7 Kanai ...
Nature 600 (7889), 472-477, 2021
7392021
High versus low positive end-expiratory pressure during general anaesthesia for open abdominal surgery (PROVHILO trial): a multicentre randomised controlled trial
PROVE Network Investigators
The Lancet 384 (9942), 495-503, 2014
5432014
A European Respiratory Society technical standard: exhaled biomarkers in lung disease
I Horváth, PJ Barnes, S Loukides, PJ Sterk, M Högman, AC Olin, A Amann, ...
European Respiratory Journal 49 (4), 2017
5372017
Incidence, risk factors, and attributable mortality of secondary infections in the intensive care unit after admission for sepsis
LA van Vught, PMCK Klouwenberg, C Spitoni, BP Scicluna, MA Wiewel, ...
Jama 315 (14), 1469-1479, 2016
5262016
Volatile metabolites of pathogens: a systematic review
LDJ Bos, PJ Sterk, MJ Schultz
PLoS pathogens 9 (5), e1003311, 2013
4582013
Autoantibodies neutralizing type I IFNs are present in~ 4% of uninfected individuals over 70 years old and account for~ 20% of COVID-19 deaths
P Bastard, A Gervais, T Le Voyer, J Rosain, Q Philippot, J Manry, ...
Science immunology 6 (62), eabl4340, 2021
4522021
Mechanical power of ventilation is associated with mortality in critically ill patients: an analysis of patients in two observational cohorts
A Serpa Neto, RO Deliberato, AEW Johnson, LD Bos, P Amorim, ...
Intensive care medicine 44, 1914-1922, 2018
4362018
Classification of patients with sepsis according to blood genomic endotype: a prospective cohort study
BP Scicluna, LA Van Vught, AH Zwinderman, MA Wiewel, EE Davenport, ...
The Lancet Respiratory Medicine 5 (10), 816-826, 2017
4352017
X-linked recessive TLR7 deficiency in~ 1% of men under 60 years old with life-threatening COVID-19
T Asano, B Boisson, F Onodi, D Matuozzo, M Moncada-Velez, ...
Science immunology 6 (62), eabl4348, 2021
3392021
Ventilation management and clinical outcomes in invasively ventilated patients with COVID-19 (PRoVENT-COVID): a national, multicentre, observational cohort study
M Botta, AM Tsonas, J Pillay, LS Boers, AG Algera, LDJ Bos, ...
The lancet Respiratory medicine 9 (2), 139-148, 2021
2852021
Identification and validation of distinct biological phenotypes in patients with acute respiratory distress syndrome by cluster analysis
LD Bos, LR Schouten, LA Van Vught, MA Wiewel, DSY Ong, O Cremer, ...
Thorax 72 (10), 876-883, 2017
2522017
Lung microbiota predict clinical outcomes in critically ill patients
RP Dickson, MJ Schultz, T Van Der Poll, LR Schouten, NR Falkowski, ...
American journal of respiratory and critical care medicine 201 (5), 555-563, 2020
2212020
Acute respiratory distress syndrome: causes, pathophysiology, and phenotypes
LDJ Bos, LB Ware
The Lancet 400 (10358), 1145-1156, 2022
2092022
Interobserver agreement of Centers for Disease Control and Prevention criteria for classifying infections in critically ill patients
PMCK Klouwenberg, DSY Ong, LDJ Bos, FM de Beer, ...
Critical care medicine 41 (10), 2373-2378, 2013
2062013
Increased incidence of co-infection in critically ill patients with influenza
I Martin-Loeches, M J Schultz, JL Vincent, F Alvarez-Lerma, LD Bos, ...
Intensive care medicine 43, 48-58, 2017
1972017
ESICM guidelines on acute respiratory distress syndrome: definition, phenotyping and respiratory support strategies
G Grasselli, CS Calfee, L Camporota, D Poole, MBP Amato, M Antonelli, ...
Intensive care medicine 49 (7), 727-759, 2023
1932023
Anti-C5a antibody IFX-1 (vilobelimab) treatment versus best supportive care for patients with severe COVID-19 (PANAMO): an exploratory, open-label, phase 2 randomised …
APJ Vlaar, S de Bruin, M Busch, SA Timmermans, IE van Zeggeren, ...
The Lancet Rheumatology 2 (12), e764-e773, 2020
1812020
Exhaled molecular fingerprinting in diagnosis and monitoring: validating volatile promises
AW Boots, LD Bos, MP van der Schee, FJ van Schooten, PJ Sterk
Trends in molecular medicine 21 (10), 633-644, 2015
1792015
The system can't perform the operation now. Try again later.
Articles 1–20